IMP Manufacture, Labelling and Packaging DPS
Introduction
The IMP Manufacture, Labelling and Packaging Dynamic Purchasing System (DPS) is an innovative procurement initiative established by the London School of Hygiene & Tropical Medicine (LSHTM). This DPS has been designed to facilitate the procurement of services related to the manufacturing, labelling, and packaging of investigational medicinal products (IMPs) used in clinical trials. Operating over a decade-long period until 22nd August 2034, it provides a streamlined and flexible procurement route, ensuring that LSHTM can efficiently source the services essential for both large and small-scale clinical trials.
Context & Use Case
The DPS is specifically tailored to support the health and social care sector, a critical area of public service that demands high standards of compliance and innovation. Contracting authorities like LSHTM utilise this DPS to access a wide range of suppliers capable of fulfilling the specific requirements of clinical trials. The investigational medicinal products are fundamental to the research and development of new treatments, and their manufacture, labelling, and packaging must adhere to stringent regulatory standards. By employing the DPS, LSHTM can ensure that these processes are conducted by competent suppliers, thus maintaining the integrity and quality of their clinical research activities.
Scope of Services
The services covered under this DPS include, but are not limited to: 1. Manufacturing of investigational medicinal products, ensuring adherence to Good Manufacturing Practice (GMP) standards. 2. Labelling of medicinal products, incorporating correct and compliant information pertinent to clinical trials. 3. Packaging services that ensure the safety and stability of medicinal products during storage and transport. 4. Quality control measures to ascertain compliance with clinical trial protocols and regulatory requirements. 5. Logistics and distribution services tailored to the needs of clinical trial settings.
Who Can Apply
The DPS is designed to be inclusive, welcoming applications from a diverse range of suppliers, including both large firms and small to medium-sized enterprises (SMEs). Suppliers with expertise in the manufacture, labelling, and packaging of medicinal products, particularly those with experience in clinical trials, are encouraged to apply. As a dynamic system, the DPS remains open for applications throughout its duration, allowing new suppliers to join and contribute their services as the needs of the sector evolve.
Buyer Benefits
Public sector buyers, like LSHTM, benefit from the DPS by gaining access to a pre-qualified pool of suppliers, facilitating compliance with public procurement regulations. The dynamic nature of the DPS allows for a swift response to emerging clinical trial needs, ensuring speed to market without compromising on competition or quality. This flexible approach helps in efficiently managing the intricate logistics involved in clinical trials, thereby supporting the overall objectives of public health initiatives.
Lots
Not applicable
Next Steps
Suppliers interested in participating in the IMP Manufacture, Labelling and Packaging DPS should begin by thoroughly reviewing the specific requirements and qualification criteria set forth by LSHTM. To ensure alignment with the needs of this DPS, potential suppliers are advised to contact LSHTM directly for further details and guidance on the application process.
How Biddable Can Help
Biddable provides essential support to suppliers exploring opportunities within public sector frameworks and DPS arrangements. Through our services, suppliers can discover relevant procurement opportunities, prepare effectively for application processes, and maintain visibility over their pipeline of potential contracts. Our goal is to facilitate a clear understanding of the procurement landscape, helping suppliers to strategically position themselves for success in public sector bidding.